Health Canada vs ANVISA: Medical Device Regulatory Comparison
Compare the medical device registration pathways, classification, and regulatory requirements of Health Canada (Canada) vs ANVISA (Brazil).
Health Canada
Health Canada — Therapeutic Products Directorate
Canada
Health Canada regulates medical devices through a four-class risk-based system. Class I devices require an establishment license, while Class II-IV require pre-market review. Canada is an MDSAP partic…
Class I, II, III, IV
MDEL (Class I), MDL (Class II-IV)
- ▸Medical Device License (MDL)
- ▸MDSAP single audit program
- ▸Incident reporting via MEDDEV
- ▸Medical Device Establishment License (MDEL)
ANVISA
Agência Nacional de Vigilância Sanitária (Brazil)
Brazil
ANVISA regulates medical devices in Brazil using a four-class risk-based system. Brazil is an MDSAP participating country. ANVISA requires a Brazilian Registration Holder (BRH) for foreign manufacture…
Class I, II, III, IV
ANVISA cadastro (Class I-II) / registro (Class III-IV)
- ▸Device registration (cadastro/registro)
- ▸Brazilian Registration Holder requirement
- ▸MDSAP participation
- ▸GMP (INMETRO) certification
- ▸ANVISA Technical Opinion
MedFlux monitors both Health Canada and ANVISA in real time — every regulatory change, safety alert, and market signal delivered in under 90 seconds.
COMPARE LIVE DATA FREE →